Protein profiling of angiogenesis-related growth factors in laryngeal carcinoma: Pattern of protein expression in relation to tumour progression

被引:5
作者
Korampalli, Tirupati S. [1 ]
Green, Victoria L. [1 ]
Greenman, John [1 ]
Stafford, Nicholas D. [1 ]
机构
[1] Univ Hull, Castle Hill Hosp, Postgrad Med Inst, Daisy Labs, Kingston Upon Hull HU16 5JQ, N Humberside, England
关键词
angiogenesis; angiogenic factors; laryngeal carcinoma; tumour progression; SQUAMOUS-CELL CARCINOMAS; PROGNOSTIC-SIGNIFICANCE; FACTOR RECEPTOR; HEAD; NECK; CANCER; SURVIVAL; MARKERS; HNSCC;
D O I
10.3892/ijo.2011.1117
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of angiogenesis-related proteins was determined in laryngeal tumour tissue, associated tumour involved lymph nodes, apparently normal mucosa and control tissue and were related to tumour stage. Both laryngeal tumour tissue and associated metastatic nodes were obtained from seven patients undergoing surgical resection; in four cases apparently normal mucosa was also dissected from the tumour specimen margins. Control uvula mucosa was obtained from five healthy volunteers undergoing uvulopalatopharyngoplasty. The relative expression of 55 angiogenesis-related proteins was determined in tissue lysates using a Proteome Profiler human angiogenesis array kit. The level of 32/55 angiogenesis-related proteins was higher in tumour tissue compared with controls. Furthermore, in these tumour biopsies higher levels of proteins were associated with increasing tumour stage. A similar trend was seen for 29/32 of these proteins in the nodal tissue. In T4 stage tumour tissue samples, 29/55 angiogenensis-related proteins were more highly expressed compared with the adjacent normal mucosa from the same patient, and this decreased to 8 proteins in tumour tissue from the T1 stage patients. In contrast, the expression of 23 angiogenesis-related proteins in metastatic lymph node tissue from T4 stage patients was lower compared with that found in the normal mucosa adjacent to the tumour. In conclusion, this study has identified a number of factors involved in angiogenesis that are likely to contribute to the growth and metastasis of laryngeal tumours. Furthermore, a number of factors were also substantially altered in metastatic deposits compared with the primary tumour mass or adjacent normal tissue. This study requires confirmatory analysis of the selected key factors in a larger cohort of patients.
引用
收藏
页码:1033 / 1039
页数:7
相关论文
共 34 条
  • [1] Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
    Ang, K. Kian
    Harris, Jonathan
    Wheeler, Richard
    Weber, Randal
    Rosenthal, David I.
    Nguyen-Tan, Phuc Felix
    Westra, William H.
    Chung, Christine H.
    Jordan, Richard C.
    Lu, Charles
    Kim, Harold
    Axelrod, Rita
    Silverman, C. Craig
    Redmond, Kevin P.
    Gillison, Maura L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) : 24 - 35
  • [2] THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES
    BASILICO, C
    MOSCATELLI, D
    [J]. ADVANCES IN CANCER RESEARCH, 1992, 59 : 115 - 165
  • [3] Biological roles of fibroblast growth factor-2
    Bikfalvi, A
    Klein, S
    Pintucci, G
    Rifkin, DB
    [J]. ENDOCRINE REVIEWS, 1997, 18 (01) : 26 - 45
  • [4] Expanding fields of genetically altered cells in head and neck squamous carcinogenesis
    Braakhuis, BJM
    Leemans, CR
    Brakenhoff, RH
    [J]. SEMINARS IN CANCER BIOLOGY, 2005, 15 (02) : 113 - 120
  • [5] The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer
    Bran, Birgit
    Bran, Gregor
    Hoermann, Karl
    Riedel, Frank
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (01) : 255 - 261
  • [6] CHAROENRAT P, 2001, ARCH OTOLARYNGOL, V127, P813
  • [7] Chen Z, 1999, CLIN CANCER RES, V5, P1369
  • [8] Novel markers for poor prognosis in head and neck cancer
    Chin, D
    Boyle, GM
    Williams, RM
    Ferguson, K
    Pandeya, N
    Pedley, J
    Campbell, CM
    Theile, DR
    Parsons, PG
    Coman, WB
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (05) : 789 - 797
  • [9] Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study
    Cohen, Ezra E. W.
    Davis, Darren W.
    Karrison, Theodore G.
    Seiwert, Tanguy Y.
    Wong, Stuart J.
    Nattam, Sreenivasa
    Kozloff, Mark F.
    Clark, Joseph I.
    Yan, Duen-Hwa
    Liu, Wen
    Pierce, Carolyn
    Dancey, Janet E.
    Stenson, Kerstin
    Blair, Elizabeth
    Dekker, Allison
    Vokes, Everett E.
    [J]. LANCET ONCOLOGY, 2009, 10 (03) : 247 - 257
  • [10] A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma
    Druzgal, CH
    Chen, Z
    Yeh, NT
    Thomas, GR
    Ondrey, FG
    Duffey, DC
    Vilela, RJ
    Ende, K
    McCullagh, L
    Rudy, SF
    Muir, C
    Herscher, LL
    Morris, JC
    Albert, PS
    Van Waes, C
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (09): : 771 - 784